Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)
China flag China · Delayed Price · Currency is CNY
30.66
+0.29 (0.95%)
Sep 29, 2026, 2:15 PM CST

SHA:688314 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
340.18341.87311.71262.63229.61206.31
Other Revenue
11.559.210.2312.410.346.24
351.72351.08321.95275.03239.95212.55
Revenue Growth
3.78%9.05%17.06%14.62%12.89%29.54%
Cost of Revenue
79.9876.7967.9360.3850.1941.99
Gross Profit
271.74274.28254.01214.65189.76170.56
Selling, General & Admin
132.6121.19119.76107.3391.5875.18
Research & Development
33.5625.6423.917.6418.316.8
Other Operating Expenses
4.784.584.644.424.032.77
Operating Expenses
172.52152.02147.96129.38114.1194.71
Operating Income
99.23122.26106.0585.2675.6475.85
Interest Expense
-2.67-2.32-2.17-1.89-1.23-0.74
Interest & Investment Income
2.112.035.225.28.144.85
Currency Exchange Gain (Loss)
-0.80.15-0.370.230.490.03
Other Non Operating Income (Expenses)
-5.46-0.72-1.75-0.3-0.2-0.17
EBT Excluding Unusual Items
92.4121.4106.9888.582.8579.82
Impairment of Goodwill
-2.19-2.19----
Gain (Loss) on Sale of Investments
-1.73-9.21-12.59-1.86--
Gain (Loss) on Sale of Assets
-0.4-0.380.44-0.06-00.02
Asset Writedown
---1.87--0.04-0.35
Other Unusual Items
8.765.8913.045.185.6615.9
Pretax Income
96.85115.5210691.7588.4695.39
Income Tax Expense
13.2217.7718.3717.2814.314.21
Earnings From Continuing Operations
83.6397.7587.6474.4774.1681.18
Minority Interest in Earnings
1.470.960.761.041.530.44
Net Income
85.198.788.475.5175.6981.63
Net Income to Common
85.198.788.475.5175.6981.63
Net Income Growth
-10.05%11.66%17.07%-0.23%-7.28%55.83%
Shares Outstanding (Basic)
828281818173
Shares Outstanding (Diluted)
828281818173
Shares Change
1.03%0.58%-0.12%-0.23%11.81%19.10%
EPS (Basic)
1.041.211.090.930.931.12
EPS (Diluted)
1.041.211.090.930.931.12
EPS Growth
-10.97%11.01%17.20%0%-17.07%30.84%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
61.9166.6592.867173.7848.05
Free Cash Flow Per Share
0.760.821.150.870.910.66
Dividend Per Share
0.4700.5200.3600.3200.3710.443
Dividend Growth
-16.07%44.44%12.50%-13.84%-16.14%19.25%
Gross Margin
77.26%78.13%78.90%78.05%79.08%80.25%
Operating Margin
28.21%34.83%32.94%31.00%31.52%35.69%
Profit Margin
24.20%28.12%27.46%27.46%31.54%38.40%
Free Cash Flow Margin
17.60%18.98%28.84%25.82%30.75%22.61%
EBITDA
117.32135.15117.5695.6285.5683.02
EBITDA Margin
33.35%38.50%36.52%34.77%35.66%39.06%
D&A For EBITDA
18.0912.8811.5110.369.917.17
EBIT
99.23122.26106.0585.2675.6475.85
EBIT Margin
28.21%34.83%32.94%31.00%31.52%35.69%
Effective Tax Rate
13.65%15.38%17.33%18.83%16.17%14.90%
Revenue as Reported
351.72351.08321.95275.03239.95212.55
Advertising Expenses
-12.8415.9317.7719.9717.68